Mutations in DHDPSL are responsible for primary hyperoxaluria type III
- PMID: 20797690
- PMCID: PMC2933339
- DOI: 10.1016/j.ajhg.2010.07.023
Mutations in DHDPSL are responsible for primary hyperoxaluria type III
Abstract
Primary hyperoxaluria (PH) is an autosomal-recessive disorder of endogenous oxalate synthesis characterized by accumulation of calcium oxalate primarily in the kidney. Deficiencies of alanine-glyoxylate aminotransferase (AGT) or glyoxylate reductase (GRHPR) are the two known causes of the disease (PH I and II, respectively). To determine the etiology of an as yet uncharacterized type of PH, we selected a cohort of 15 non-PH I/PH II patients from eight unrelated families with calcium oxalate nephrolithiasis for high-density SNP microarray analysis. We determined that mutations in an uncharacterized gene, DHDPSL, on chromosome 10 cause a third type of PH (PH III). To overcome the difficulties in data analysis attributed to a state of compound heterozygosity, we developed a strategy of "heterozygosity mapping"-a search for long heterozygous patterns unique to all patients in a given family and overlapping between families, followed by reconstruction of haplotypes. This approach enabled us to determine an allelic fragment shared by all patients of Ashkenazi Jewish descent and bearing a 3 bp deletion in DHDPSL. Overall, six mutations were detected: four missense mutations, one in-frame deletion, and one splice-site mutation. Our assumption is that DHDPSL is the gene encoding 4-hydroxy-2-oxoglutarate aldolase, catalyzing the final step in the metabolic pathway of hydroxyproline.
2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Re: Mutations in DHDPSL are Responsible for Primary Hyperoxaluria Type III.J Urol. 2011 Apr;185(4):1312. doi: 10.1016/j.juro.2010.12.022. Epub 2011 Feb 22. J Urol. 2011. PMID: 22115483 No abstract available.
References
-
- Danpure C.J., Jennings P.R. Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett. 1986;201:20–24. - PubMed
-
- Cregeen D.P., Williams E.L., Hulton S., Rumsby G. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2. Hum. Mutat. 2003;22:497. - PubMed
-
- Monico C.G., Persson M., Ford G.C., Rumsby G., Milliner D.S. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int. 2002;62:392–400. - PubMed
-
- Monico C.G., Weinstein A., Jiang Z., Rohlinger A.L., Cogal A.G., Bjornson B.B., Olson J.B., Bergstralh E.J., Milliner D.S., Aronson P.S. Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis. Am. J. Kidney Dis. 2008;52:1096–1103. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
